Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth M Zeisberg

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Scientific Reports|December 16, 2021
PP2A phosphatase inhibition is anti-fibrotic through Ser77 phosphorylation-mediated ARNT/ARNT homodimer formationGunsmaa Nyamsuren, Gregor Rapp, Hassan Dihazi, et al.
Plos One|September 3, 2011
Circulating endoglin concentration is not elevated in chronic kidney diseaseDavid M Charytan, Alexander M Helfand, Brian A MacDonald, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 28, 2018
Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage functionAlexandra Helmke, Janis Casper, Johannes Nordlohne, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 30, 2025
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosolsAchim Biesel, Sabine Maamari, Nils Salaw, et al.
Theranostics|April 1, 2020
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1Tim Wilhelmi, Xingbo Xu, Xiaoying Tan, et al.
The Journal of Clinical Investigation|May 20, 2005
Morphogenesis of the right ventricle requires myocardial expression of Gata4Elisabeth M Zeisberg, Qing Ma, Amy L Juraszek, et al.
Ebiomedicine|February 27, 2015
Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney DiseaseBjörn Tampe, Desiree Tampe, Elisabeth M Zeisberg, et al.
Kidney International|October 4, 2016
Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progressionBjörn Tampe, Ulrike Steinle, Désirée Tampe, et al.
Nature Medicine|April 27, 2010
Methylation determines fibroblast activation and fibrogenesis in the kidneyWibke Bechtel, Scott McGoohan, Elisabeth M Zeisberg, et al.
Clinical Epigenetics|August 27, 2024
Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair responseSandip Kumar Rath, Gunsmaa Nyamsuren, Björn Tampe, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Scientific Reports|December 16, 2021
PP2A phosphatase inhibition is anti-fibrotic through Ser77 phosphorylation-mediated ARNT/ARNT homodimer formationGunsmaa Nyamsuren, Gregor Rapp, Hassan Dihazi, et al.
Plos One|September 3, 2011
Circulating endoglin concentration is not elevated in chronic kidney diseaseDavid M Charytan, Alexander M Helfand, Brian A MacDonald, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 28, 2018
Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage functionAlexandra Helmke, Janis Casper, Johannes Nordlohne, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 30, 2025
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosolsAchim Biesel, Sabine Maamari, Nils Salaw, et al.
Theranostics|April 1, 2020
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1Tim Wilhelmi, Xingbo Xu, Xiaoying Tan, et al.
The Journal of Clinical Investigation|May 20, 2005
Morphogenesis of the right ventricle requires myocardial expression of Gata4Elisabeth M Zeisberg, Qing Ma, Amy L Juraszek, et al.
Ebiomedicine|February 27, 2015
Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney DiseaseBjörn Tampe, Desiree Tampe, Elisabeth M Zeisberg, et al.
Kidney International|October 4, 2016
Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progressionBjörn Tampe, Ulrike Steinle, Désirée Tampe, et al.
Nature Medicine|April 27, 2010
Methylation determines fibroblast activation and fibrogenesis in the kidneyWibke Bechtel, Scott McGoohan, Elisabeth M Zeisberg, et al.
Clinical Epigenetics|August 27, 2024
Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair responseSandip Kumar Rath, Gunsmaa Nyamsuren, Björn Tampe, et al.
Pageof 6